INVA CIK: 1080014

Innoviva, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
364
FY22:
202
FY23:
141
FY24:
189
FY25:
197
Change from FY21 to FY25
millions USD
FY21:
43.7
FY22:
−56.6
FY23:
−66.8
FY24:
−63.8
FY25:
40.5
Change from FY21 to FY25
millions USD
FY21:
−452
FY22:
−55.6
FY23:
−172
FY24:
−13.5
FY25:
8.55
millions USD
FY21:
−45.0
FY22:
89.5
FY23:
−97.5
FY24:
111
FY25:
246
(positive)
Change from FY21 to FY25
millions USD
FY21:
364
FY22:
202
FY23:
141
FY24:
188
FY25:
196

All amounts in millions USD Data source:SEC EDGAR